期刊文献+

静脉人工血管桥内膜增生的形态学特征及洛伐他汀的干预作用 被引量:1

Histological character of intimal hyperplasia post jugular vein grafts and the protective effect of lovastatin
暂未订购
导出
摘要 目的:探讨静脉人工血管桥内膜增生特点及洛伐他汀可能的干预作用。方法:实验犬12只,随机分为实验组和对照组,建立颈静脉人工血管搭桥模型,以洛伐他汀作为实验干预药物,4周后取出人工血管标本,观察人工血管通畅情况,观察吻合口内膜增生形态、厚度以及新生小血管情况等,并比较两组间的差异。结果:术后4周,实验组与对照组均有3条人工血管完全闭塞,全部吻合口均可见明显内膜增生,实验组近端、远端内膜增生厚度低于对照组(P值分别为0.045,0.040),增生内膜表面可见内皮细胞覆盖,增生内膜中可见新生小血管形成,实验组近、远端内膜中新生小血管的数量均多于对照组(P值分别为0.041,0.031)。结论:4周时,吻合口内膜增生明显,同时伴有新生小血管形成,洛伐他汀可以减少内膜增生的厚度,并能够促进新生小血管的形成。 Objective: To investigate the characteristics of intimal hyperplasia and lovastatin's effects on canine jugular venous prosthesis bypass grafting.Methods: In the study,12 adult mistus dogs were randomly divided into 2 groups: lovastatin group and control group.All the dogs were performed with jugular venous prosthesis bypass grafting(ePTFE,6 mm in diameter,and 5 cm in length).Four weeks later,all the 12 specimens were harvested.The patency and mural thrombus of grafts were evaluated.The characteristics of intimal hyperplasia were described and measured by HE staining and endothelial nitric oxide synthase(eNOs) immunohistochemical method.The differences between the two groups were compared.Results: Four weeks later,3 grafts with complete occlusion were found in the two groups separately.Apparent intimal hyperplasia was observed in all the grafts.The neointima of proximal and distal part in lovastatin group were thinner than in control group respectively(proximal P=0.045,distal P=0.040).The endothelial cells were found in the surface of neointima.Newly born vessels could be found in the neointima and the new vessels were more in lovastatin group than in control group(proximal P=0.041,distal P=0.031).Conclusion: At the end of 4 weeks,the intimal hyperplasia with neovascularization was obviously near the anastomosis.Lovastatin showed the ability to inhibit the intimal hyperplasia and promote the neovascularization.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2012年第5期783-787,共5页 Journal of Peking University:Health Sciences
关键词 人工血管 血管内膜 增生 洛伐他汀 Blood vessel prosthesis Tunica intima Hyperplasia Lovastatin
  • 相关文献

参考文献10

  • 1Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accele- rates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells [J]. Circulation, 2002, 105(25) : 3017 -3024.
  • 2Martinez-Gonzdlez J, Badimon L. Influence of statin use on endo- thelial function: from bench to clinics [J]. CUlT Pharm Des, 2007, 13(17): 1771-1786.
  • 3Walter DH, Dimmeler S, Zeiher AM. Effects of statins on endo- thelium and endothelial progenitor cell recruitment [ J ]. Semin Vasc Med, 2004, 4(4) : 385 -393.
  • 4Calabro P, Yeh TH. The pleiotropic effects of statins [J]. J Curr Opin Cardiol, 2005, 20(6): 541 -546.
  • 5Mason JC. Statins and their role in vascular protection [ J]. Clin Sci (Lond) , 2003, 105 (3) : 251 - 266.
  • 6Hu Y, Tong G, Xu W, et al. Anti-inflammatory effects of simvas- tatin on adipokines in type 2 diabetic patients with carotid athero- sclerosis [J]. Diab Vasc Dis Res, 2009, 6(4) : 262 -268.
  • 7Aydin U, Ugurlucan M, Gungor F, et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model [ J ]. Angiology, 2009, 60(3): 370- 377.
  • 8Fujita H, Banno H, Yamanouchi D, et al. Pitavastatin inhibits in- timal hyperplasia in rabbit vein graft [ J]. J Surg Res, 2008, 148 (2):238 -243.
  • 9翟国钧,董国祥,赵军,姚伟娟.洛伐他汀对人血管内皮细胞双向调节作用的实验研究[J].中华普通外科杂志,2010,25(8):665-667. 被引量:2
  • 10Khaidakov M, Wang W, Khan JA, et al. Statins and angiogene- sis: Is it about connections? [ J]. Biochem Biophys Res Commun, 2009, 387(3): 543-547.

二级参考文献9

  • 1Walter DH,Rittig K,Bahlmann FH,et al.Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.Circulation,2002,105:3017-3024.
  • 2Karthikeyan VJ,Lip GY.Statins and intra-placue angiogenesis in carotid artery disease.Atherosclerosis,2007,192:455-456.
  • 3Poynter JN,Gruber SB,Higgins PD,et al.Statins and the risk of colorectal cancer.N Engl J Med,2005,352:2184-2192.
  • 4Dulak J,Józkowicz A.Anti-angiogenic and anti-inflammatory effects of statins:relevance to anti-cancer therapy.Curr Cancer Drug Targets,2005,5:579-594.
  • 5Mason JC.Statins and their role in vascular protection.Clinical Science,2003,105:251-266.
  • 6Li XX,Han YY,Pang W,et al.AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells.Arterioscler Thromb Vasc Bio,2008,28:1789-1795.
  • 7Michael W,Christopher H,Alec JG,et al.Statins Have Biphasic Effects on Angiogenesis.Circulation,2002,105:739-745.
  • 8Khaidakov M,Wang W,Khan JA,et al.Statins and angiogenesis:is it about connections? Biochem Biophys Res Commun,2009,387:543-547.
  • 9Abbruzzese TA,Havens J,Belkin M,et al.Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.J Vasc Surg,2004,39:1178-1185.

共引文献1

同被引文献16

  • 1Schillinger M, Exner M, Mlekusch W, et al. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts[J]. J Endovasc Ther, 2003, 10: 557 - 565.
  • 2Siracuse JJ, Giles KA, Pomposelli FB, et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease[J]. J Vase Surg, 2012, 55: 1001 -1007.
  • 3Schwartz RS, Henry TO. Pathophysiology of coronary artery restenosis [J]. Rev Cardiovasc Med, 2002, 3 (suppl 5): S4 - S9.
  • 4Owens CD. Statins and other agents for vascular inflammation [J]. J Vase Surg, 2012, 56: 1799 - 1806.
  • 5Antonopoulos AS, Margaritis M, Shirodaria C, et al. Translating the effects of statins. from redox regulation to suppression of vascular wall inflammation [J]. Thromb Haemost, 2012, 108: 840 - 848.
  • 6Ali FN, Carman TL. Medical management for chronic atherosclerotic peripheral arterial disease[J]. Drugs, 2012, 72: 2073 - 2085.
  • 7Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed , American College of Chest Physicians Evidence - Based Clinical Practice Guidelines [J]. Chest, 2012, 141: e669S - e690S.
  • 8Korybalska K, Kawka E, Breborowicz A, et al. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury[J]. J Physiol Pharmacol, 2012, 63: 389 - 395.
  • 9Ewa D, Michael HD. A review of lipid management in primary and secondary prevention [J]. J Cardiopulm Rehabil Prev, 2009, 29: 2 - 12.
  • 10Zhou Q, Liao JK. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy [J]. Curr Pharm Des, 2009, 15: 467 - 478.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部